News Daily News Statins Underprescribed in PAD Before and After Interventions L.A. McKeown December 03, 2021
News Conference News ACC 2021 Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions L.A. McKeown May 21, 2021
News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020
News Daily News ‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia L.A. McKeown November 24, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Daily News Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors L.A. McKeown September 16, 2019
News Daily News AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL L.A. McKeown January 03, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2018 Shelley Wood October 02, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News CMS Lauded for Coverage Decision on Supervised Exercise Therapy for PAD L.A. McKeown June 08, 2017
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Daily News Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling L.A. McKeown May 01, 2017
News Conference News ISET 2017 Routine Screening of ABI to Identify PAD: Despite Guidelines, One Expert Asks Why Not? Caitlin E. Cox February 06, 2017